-+ 0.00%
-+ 0.00%
-+ 0.00%

Conexeu Sciences Introduces Human Collagen Program For Regenerative Aesthetics

Benzinga·11/10/2026 13:35:24
Listen to the news

Conexeu Sciences Inc. (NASDAQ:CNXU) ("Conexeu" or the "Company"), a preclinical-stage medical device and regenerative medicine company advancing CXU™, an investigational tissue-restoration platform, today announced a human collagen program for regenerative aesthetics, starting with the production of its first pilot batch of human type I collagen.